Sort
34,240 grants matching “atherosclerosis”
Post-transcriptional regulation of LDLR
$777,112Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2024 · HL
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites
$777,067Qibin Qi · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
$777,063Gary K Owens · University Of Virginia · R01 · FY2024 · HL
Framingham: Inflammation, Genes & Cardiovascular Disease
$777,030Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2006 · HL
Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease
$777,013Luke Packard Brewster · Emory University · R01 · FY2019 · HL
Subclinical Interstitial Lung Disease in MESA and FAR-ILD
$776,942Christine Kim Garcia · Columbia University Health Sciences · R01 · FY2020 · HL
Using genomics and functional biology to understand fibrinogen and its effect on thrombotic and atherosclerotic outcomes
$776,923Alanna C Morrison · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · HL
Selectin targeted ultrasound contrast agents for detection of acute coronary synd
$776,859Joshua J. Rychak · Targeson, Inc. · R44 · FY2014 · HL
The Risk of Myocardial Infarction in Patients with Psoriasis
$776,528Joel M Gelfand · University Of Pennsylvania · R01 · FY2011 · HL
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain
$776,419Elizabeth A Proctor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AG
Epidemiology of Venous Thrombosis and Pulmonary Embolism
$776,400Aaron R Folsom · University Of Minnesota · R01 · FY2017 · HL
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
$776,388Gang Bao · Rice University · UG3 · FY2019 · HL
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease
$776,382Loren Eugene Wold · Ohio State University · R01 · FY2019 · AG
Local B-1 Regulation of Atherosclerosis
$776,373Coleen A McNamara · University Of Virginia · R01 · FY2020 · HL
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
$776,366Atul Malhotra · University Of California, San Diego · R01 · FY2025 · HL
National Gnotobiotic Resource Center
$776,328Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2024 · OD
National Gnotobiotic Resource Center
$776,328Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2025 · OD
Lifestyle effects on hematopoiesis and atherosclerosis
$776,297Filip K Swirski · Massachusetts General Hospital · R01 · FY2015 · HL
A Just-In-Time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Hypertensive Patients
$776,114Michael Dorsch · University Of Michigan At Ann Arbor · R61 · FY2021 · HL
Community Translation of the South Asian Healthy Lifestyle Intervention (SAHELI)
$776,078Namratha R Kandula · Northwestern University At Chicago · R01 · FY2017 · HL
FIRST-IN-HUMAN TRIAL OF A RECEPTOR-TARGETED NANOPARTICLE PET TRACER FOR ATHEROSCLEROSIS
$776,028Pamela K Woodard · Washington University · R01 · FY2017 · HL
Quantitative cerebral blood vessel imaging biomarkers for AD and VCID
$775,949Lirong Yan · Northwestern University At Chicago · R01 · FY2025 · AG
Atherosclerosis Risk in Communities Study (ARIC)
$775,948Baylor College Of Medicine · N01 · FY2008 · HL
ApoE receptor-2 in vascular disease progression and regression
$775,946David Y Hui · University Of Cincinnati · R01 · FY2021 · HL
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes
$775,846George L King · Joslin Diabetes Center · R01 · FY2023 · HL